Access to anti-retroviral drugs, male in Suriname

Suriname: Access to anti-retroviral drugs, male was 41.0% in 2024. ◆ Volatile

Latest (2024)
41.0%
Change on year
up 2.5%
World rank
130th
of 141 countries
All-time high
41.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Suriname, 2000–2024

0102030402000201220242000: 0 %2001: 0 %2002: 1 %2003: 2 %2004: 4 %2005: 6 %2006: 7 %2007: 10 %2008: 12 %2009: 14 %2010: 15 %2011: 17 %2012: 21 %2013: 22 %2014: 25 %2015: 26 %2016: 29 %2017: 31 %2018: 33 %2019: 33 %2020: 38 %2021: 36 %2022: 33 %2023: 40 %2024: 41 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, male in Suriname stood at 41.0%. That is the highest value across all 25 years on record.

Compared with earlier readings it is up 2.5% on the previous year and up 64.0% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Suriname peaked at 41.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Suriname 130th out of 141 countries with data for 2024, putting it in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Suriname, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Suriname, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 1.0%
2003 2.0% +100.0%
2004 4.0% +100.0%
2005 6.0% +50.0%
2006 7.0% +16.7%
2007 10.0% +42.9%
2008 12.0% +20.0%
2009 14.0% +16.7%
2010 15.0% +7.1%
2011 17.0% +13.3%
2012 21.0% +23.5%
2013 22.0% +4.8%
2014 25.0% +13.6%
2015 26.0% +4.0%
2016 29.0% +11.5%
2017 31.0% +6.9%
2018 33.0% +6.5%
2019 33.0% +0.0%
2020 38.0% +15.2%
2021 36.0% -5.3%
2022 33.0% -8.3%
2023 40.0% +21.2%
2024 41.0% +2.5%

Averages by decade

DecadeAverage LowestHighest Years
2000s 5.6% 0.0% 14.0% 10
2010s 25.2% 15.0% 33.0% 10
2020s 37.6% 33.0% 41.0% 5

Countries ranked near Suriname

  1. 128 Mongolia 42.0% compare
  2. 128 Philippines 42.0% compare
  3. 131 Congo 40.0% compare
  4. 131 Ghana 40.0% compare
  5. 133 Djibouti 28.0% compare
  6. 133 Fiji 28.0% compare
  7. 133 Tunisia 28.0% compare

See the full ranking of 160 places →

More gender data for Suriname

All data for Suriname →

Frequently asked questions

What is access to anti-retroviral drugs, male in Suriname?
Access to anti-retroviral drugs, male in Suriname was 41.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Suriname?
The highest recorded value was 41.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Suriname?
The lowest recorded value was 0.0% in 2000.
How does Suriname rank for access to anti-retroviral drugs, male?
Suriname ranks 130th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Suriname?
Over the last ten years it is up 64.0%. The long-run trend across the full record is volatile.
Where does this Suriname data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Suriname. Statizoid, drawing on UNAIDS estimates. Retrieved 11 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/suriname/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/suriname/">Access to anti-retroviral drugs, male in Suriname</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.